文献速递临床试验与 GCP

针刀治疗膝骨关节炎的有效性与安全性:随机对照试验研究方案

Effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-11-20

本研究为平行组、评估者盲法的随机对照试验,计划招募200例膝骨关节炎患者,按1:1随机分为两组。A组接受针刀联合双氯芬酸二乙胺外用4周,D组仅接受双氯芬酸二乙胺外用4周。主要结局为第4周时疼痛和功能达到最小临床重要改善的反应率,次要结局包括疼痛、功能、生活质量、 rescue 药物使用及不良事件,并检测关节液和血清炎症因子。

要点

  • 针刀治疗膝骨关节炎的证据有限,本试验旨在评估其有效性与安全性。
  • A组为针刀联合双氯芬酸二乙胺外用,D组为单用双氯芬酸二乙胺外用,疗程均为4周。
  • 主要结局为第4周疼痛和功能达到最小临床重要改善的反应率。

核心结论

  • 本研究将有助于更好地理解针刀联合外用非甾体抗炎药治疗膝骨关节炎的有效性与安全性。
  • 若假设得到证实,针刀可能被推荐作为膝骨关节炎患者的辅助治疗。
  • 研究结果将对临床治疗指南具有重要意义。

研究设计与样本

  • 平行组、评估者盲法随机对照试验。
  • 计划招募200例膝骨关节炎患者,按1:1比例随机分配至A组或D组。

关键数值与推荐

  • A组接受针刀联合双氯芬酸二乙胺外用,疗程4周。
  • D组仅接受双氯芬酸二乙胺外用,疗程4周。
  • 主要结局为第4周时疼痛和功能达到最小临床重要改善的反应率(较基线比较)。
  • 次要结局包括第4、8、24周时的疼痛、功能、生活质量、 rescue 药物(洛索洛芬钠)使用及不良事件。
  • 收集关节液和血清评估炎症细胞因子水平,如TNF-α、IL-1β和MMP-3。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Knee osteoarthritis (KOA) is one of the most common musculoskeletal disorders. Acupotomy may be effective for KOA, but the evidence is limited. This trial aims to determine the effectiveness and safety of acupotomy for KOA. METHODS/DESIGN: This is a parallel-group, assessor-blinded randomized controlled trial. Two hundred patients with KOA will be recruited and randomly assigned to two groups (group A or group D) in a 1:1 ratio. Patients in group A will receive acupotomy and topical diclofenac diethylamine for 4 weeks, while patients in group D will receive topical diclofenac diethylamine alone for 4 weeks. The primary outcome will be the response rate-the proportion of patients who achieve the minimal clinically important improvement in pain and function at week 4 compared with baseline. Secondary outcomes will include pain, function, quality of life, the use of rescue medicine (loxoprofen sodium), and adverse events at weeks 4, 8, and 24 after randomization. Besides, joint fluid and serum will be collected to assess the level of inflammatory cytokines, like TNF-α, IL-1β, and MMP-3. DISCUSSION: This study will contribute to a better understanding of the effectiveness and safety of acupotomy in combination with topical nonsteroidal anti-inflammatory drugs. If the hypothesis is confirmed, acupotomy may be recommended as adjunctive therapy for patients with KOA. Results of the study will be of great importance for the guidelines of clinical therapy. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2100043005 Registered on 4 February 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li SM, Li TL, Guo R, et al. Effectiveness and safety of acupotomy for knee osteoarthritis: study protocol for a randomized controlled trial. Trials. 2021. PMID: 34801083. doi:10.1186/s13063-021-05786-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。